Global Diabetes Cases Double Since 1990, Underscoring Treatment Gaps
A new Lancet study reveals over 800 million people globally have diabetes—double the 1990 figure—with the largest increases in low- and middle-income countries due to lifestyle changes and limited treatment access; resulting in over 445 million untreated adults in 2022.
Global Diabetes Cases Double Since 1990, Underscoring Treatment Gaps
A new Lancet study reveals over 800 million people globally have diabetes—double the 1990 figure—with the largest increases in low- and middle-income countries due to lifestyle changes and limited treatment access; resulting in over 445 million untreated adults in 2022.
Progress
36% Bias Score
FDA Approves Zepbound for Obstructive Sleep Apnea Treatment
The FDA approved Eli Lilly's Zepbound (tirzepatide) as the first medication to treat obstructive sleep apnea in obese adults, following two successful 52-week studies demonstrating significant symptom reduction.
FDA Approves Zepbound for Obstructive Sleep Apnea Treatment
The FDA approved Eli Lilly's Zepbound (tirzepatide) as the first medication to treat obstructive sleep apnea in obese adults, following two successful 52-week studies demonstrating significant symptom reduction.
Progress
32% Bias Score
Children's Heart Health Declines at Age 10, Increasing Adult Disease Risk
Research reveals that children's heart health begins deteriorating around age 10 due to poor lifestyle choices, increasing their risk of heart attacks and strokes as adults; the study involved over 1,500 children aged 3-16 in Massachusetts.
Children's Heart Health Declines at Age 10, Increasing Adult Disease Risk
Research reveals that children's heart health begins deteriorating around age 10 due to poor lifestyle choices, increasing their risk of heart attacks and strokes as adults; the study involved over 1,500 children aged 3-16 in Massachusetts.
Progress
44% Bias Score
Greece Launches New Obesity Drug Amidst Booming Market
Greece launched tirzepatide, a weekly injectable obesity drug costing \"253.05 EUR\", promising \"20%\" weight loss; high demand is expected, reflecting a \"200 billion USD\" market projection by 2030 and innovation in transdermal delivery systems.
Greece Launches New Obesity Drug Amidst Booming Market
Greece launched tirzepatide, a weekly injectable obesity drug costing \"253.05 EUR\", promising \"20%\" weight loss; high demand is expected, reflecting a \"200 billion USD\" market projection by 2030 and innovation in transdermal delivery systems.
Progress
44% Bias Score
France Approves Wegovy Reimbursement for Severely Obese Adults
France's Haute Autorité de Santé (HAS) approved Wegovy reimbursement for severely obese adults (BMI ≥35 kg/m²), following new data demonstrating reduced cardiovascular risks and approximately 17% weight loss; the drug, costing €274–€365 monthly, necessitates combined use with diet and exercise.
France Approves Wegovy Reimbursement for Severely Obese Adults
France's Haute Autorité de Santé (HAS) approved Wegovy reimbursement for severely obese adults (BMI ≥35 kg/m²), following new data demonstrating reduced cardiovascular risks and approximately 17% weight loss; the drug, costing €274–€365 monthly, necessitates combined use with diet and exercise.
Progress
36% Bias Score
US Life Expectancy to Increase Minimally by 2050, Lagging Behind Other Nations
A new study projects a small increase in US life expectancy to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdoses, and other health risks, highlighting the need for improved health policies.
US Life Expectancy to Increase Minimally by 2050, Lagging Behind Other Nations
A new study projects a small increase in US life expectancy to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdoses, and other health risks, highlighting the need for improved health policies.
Progress
48% Bias Score
Brain's Control of Intestinal Fat Absorption Suggests New Obesity Treatments
Researchers in Shanghai discovered that the brain regulates intestinal fat absorption in mice by controlling the length of microvilli in the jejunum via the vagus nerve; inactivating the nerve's dorsal motor nucleus reduces fat absorption and weight, while activation increases it, suggesting potenti...
Brain's Control of Intestinal Fat Absorption Suggests New Obesity Treatments
Researchers in Shanghai discovered that the brain regulates intestinal fat absorption in mice by controlling the length of microvilli in the jejunum via the vagus nerve; inactivating the nerve's dorsal motor nucleus reduces fat absorption and weight, while activation increases it, suggesting potenti...
Progress
36% Bias Score
FDA Approves First Prescription Drug for Obstructive Sleep Apnea
The FDA approved Zepbound, a GLP-1 receptor agonist, as the first prescription drug for moderate-to-severe obstructive sleep apnea in obese patients; clinical trials showed significant improvements in breathing disruptions and weight loss (18-20%), potentially impacting the 30 million Americans with...
FDA Approves First Prescription Drug for Obstructive Sleep Apnea
The FDA approved Zepbound, a GLP-1 receptor agonist, as the first prescription drug for moderate-to-severe obstructive sleep apnea in obese patients; clinical trials showed significant improvements in breathing disruptions and weight loss (18-20%), potentially impacting the 30 million Americans with...
Progress
44% Bias Score
Obesity Crisis: Lifestyle vs. Drugs
President-elect Trump's nominees offer opposing views on solving America's 40% adult obesity rate: Robert F. Kennedy Jr. advocates lifestyle changes, while Elon Musk champions affordable GLP-1 inhibitors; experts debate the balance between these approaches, considering the challenges of long-term li...
Obesity Crisis: Lifestyle vs. Drugs
President-elect Trump's nominees offer opposing views on solving America's 40% adult obesity rate: Robert F. Kennedy Jr. advocates lifestyle changes, while Elon Musk champions affordable GLP-1 inhibitors; experts debate the balance between these approaches, considering the challenges of long-term li...
Progress
16% Bias Score
Dutch Council Urges Fines for Supermarkets Selling Unhealthy Food
The Dutch Health Council advises the government to fine supermarkets selling too much unhealthy food and reward those promoting healthier options at checkout, aiming to curb rising obesity rates projected to affect 64% of the population by 2050.
Dutch Council Urges Fines for Supermarkets Selling Unhealthy Food
The Dutch Health Council advises the government to fine supermarkets selling too much unhealthy food and reward those promoting healthier options at checkout, aiming to curb rising obesity rates projected to affect 64% of the population by 2050.
Progress
44% Bias Score
Ultra-Processed Foods Linked to Increased Thigh Muscle Fat
A study of 666 individuals found a correlation between higher ultra-processed food consumption and increased intramuscular thigh fat, regardless of calorie intake, BMI, or activity levels, suggesting a direct impact on muscle health and potentially conditions like osteoarthritis and type 2 diabetes.
Ultra-Processed Foods Linked to Increased Thigh Muscle Fat
A study of 666 individuals found a correlation between higher ultra-processed food consumption and increased intramuscular thigh fat, regardless of calorie intake, BMI, or activity levels, suggesting a direct impact on muscle health and potentially conditions like osteoarthritis and type 2 diabetes.
Progress
36% Bias Score
US Life Expectancy to Rise Minimally, Lagging Behind Other Nations
US life expectancy is projected to increase minimally to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdose deaths, and other health risks; this will drop the US to 66th globally in life expectancy rankings from 49th in 2022.
US Life Expectancy to Rise Minimally, Lagging Behind Other Nations
US life expectancy is projected to increase minimally to 80.4 years by 2050, lagging behind other high-income nations due to rising obesity, drug overdose deaths, and other health risks; this will drop the US to 66th globally in life expectancy rankings from 49th in 2022.
Progress
56% Bias Score